If your email program has trouble displaying this email, view as a webpage.

Update: SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests

Today, the U.S. Food and Drug Administration (FDA) updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to:

• add Xtrava Health SPERA COVID-19 Ag Test as a test expected to have reduced performance with certain SARS-CoV-2 Omicron Sub-Variants.

Questions?

If you have questions about this update, email COVID19DX@fda.hhs.gov